|
Inconsistent Disease-target Association score from webpage
|
|
1
|
16
|
8 August 2025
|
|
Variant table and VEP annotations
|
|
4
|
25
|
1 August 2025
|
|
MCP server for Open Targets Data
|
|
3
|
145
|
5 July 2025
|
|
OT Platform GWAS credible set issue where there are no L2G predictions > 0.05— being resolved
|
|
4
|
87
|
6 June 2025
|
|
Credible set variants with PIP but no L2G score
|
|
1
|
24
|
6 June 2025
|
|
How to retrieve & compare study-specific GWAS variant lists (e.g., UKB vs FinnGen) for a phenotype?
|
|
1
|
59
|
8 May 2025
|
|
Negative associations
|
|
2
|
32
|
5 April 2025
|
|
Disease related targets could not be retrieved
|
|
1
|
23
|
31 March 2025
|
|
Clarification on Number of Protein-Coding Drug Targets in OpenTargets Database
|
|
1
|
46
|
31 March 2025
|
|
Downloadble drug indication data - 'Known drug' vs. 'Drug - indications'
|
|
2
|
23
|
31 March 2025
|
|
Disease related target data cannot be downloaded
|
|
2
|
50
|
31 March 2025
|
|
Deprecated term: Dermatitis, atopic (MONDO:0011292) (25.03 release)
|
|
1
|
45
|
26 March 2025
|
|
Best practices for using a pre-trained L2G pipeline on new loci
|
|
5
|
90
|
25 March 2025
|
|
Human protein atlas - baseline expression
|
|
2
|
51
|
24 March 2025
|
|
Uploading list of target _advanced_filte
|
|
1
|
28
|
24 March 2025
|
|
Data sources for V2G Scoring
|
|
5
|
60
|
13 March 2025
|
|
Understanding the data available online
|
|
1
|
42
|
25 February 2025
|
|
MaxIndicationPhase being -1 in clinical trials dataset in OpenTargets Platform- what does it mean?
|
|
1
|
15
|
21 February 2025
|
|
Discrepancy in Evidence Counts Between GraphQL API and BigQuery for enableIndirect: true
|
|
5
|
67
|
14 February 2025
|
|
Subcellular location and species in the 'Targets' data downloads dataset
|
|
4
|
359
|
5 February 2025
|
|
Clinical vs. pre-clinical safety liability data
|
|
2
|
26
|
2 December 2024
|
|
Clickhouse and Elasticsearch Databases
|
|
1
|
62
|
24 October 2024
|
|
Different Association datasets
|
|
5
|
89
|
15 October 2024
|
|
How to Obtain Descriptions for Tables and Columns
|
|
2
|
43
|
1 October 2024
|
|
How to Interpret and Utilize the Evidence Scores in Open Targets?
|
|
1
|
53
|
27 September 2024
|
|
'Target Distribution' and 'Target Specificity'
|
|
2
|
53
|
26 August 2024
|
|
Why does OT distinguish between phenotypes and diseases? or sometimes between disease and disease with the same name?
|
|
2
|
41
|
23 August 2024
|
|
Correlation between disease and tissue
|
|
2
|
48
|
14 August 2024
|
|
Drug-indication/Clinical precedence pairs on Open Targets
|
|
1
|
38
|
13 August 2024
|
|
Treatment of drug combinations
|
|
2
|
41
|
29 July 2024
|